100 of the hottest medtech startups of 2020 will share their plans for growth and investment/partnering needs to a full house of investors and strategics.
LAGUNA NIGUEL, Calif.–(BUSINESS WIRE)–#lsintelligence—Life Science Intelligence (LSI) is hosting the Emerging Medtech Summit February 18-20th, 2020 at The Ritz-Carlton in Laguna Niguel, CA. The event is drawing attendance from major medtech investors and strategics looking to partner with new medical device, diagnostic, digital health and other healthtech innovators.
In addition to startup CEO presentations, the event will include panel discussions on timely industry topics with venture capitalists, large corporates, and industry thought leaders.
Registration will close on February 15th or sooner and attendance is limited. Registration and full program details are here.
Investors attending: JJDC, Sante Ventures, Connecticut Innovations, US Venture Partners, NEA, Pangaea Ventures, SV Health Investors, Miraki Innovation Fund, MVM Partners, Evonik VC, Sands Capital, Mayo Clinic Ventures, HealthTech Capital, Grey Sky Venture Partners, and more.
Strategics attending: J&J, Medtronic, Boston Scientific, Edwards Lifesciences, Terumo, Fresenius, Intuitive Surgical, BD, W.L. Gore, and more.
Startup presenting companies:
About Life Science Intelligence (LSI)
LSI is a medical technology focused market intelligence & consulting company. We help medtech executives make informed strategic decisions by better understanding market dynamics, trends, opportunities and the competitive landscape.
Contacts
Maricela Almonte
Life Science Intelligence
714 847 3540 Tel
maricela@LS-intel.com
Boards and executive buyers are raising the 2026 bar for all product and service rankings…
Boards and executive buyers are raising the 2026 bar for all product and service rankings…
Tampa based Celebrity Board-Certified Plastic Surgeon Dr. Meegan Gruber expands an interactive approach that allows…
Clemson University and Nordic Wellness have launched a pioneering partnership tackling the student mental health…
Telehealth Platform Offers Compounded GLP-1 Injections and Oral Tablets at $299/Month With No Contract as…
MINNEAPOLIS, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (“Vireo”) (CSE: VREO; OTCQX: VREOF)…